about
Experience of road and other trauma by the opiate dependent patient: a survey reportImpact of cocaine abuse on HIV pathogenesisVitamin D receptor and epigenetics in HIV infection and drug abuseDrug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohortsMorphine induces expression of platelet-derived growth factor in human brain microvascular endothelial cells: implication for vascular permeabilityCocaine enhances HIV-1 replication in CD4+ T cells by down-regulating MiR-125bBlack race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study.Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes.Cocaine Use and Liver Disease are Associated with All-Cause Mortality in the Miami Adult Studies in HIV (MASH) Cohort.HIV-1 neuroimmunity in the era of antiretroviral therapy.Small molecules as friends and foes of the immune system.Cocaine alters cytokine profiles in HIV-1-infected African American individuals in the DrexelMed HIV/AIDS genetic analysis cohortUnhealthy substance-use behaviors as symptom-related self-care in persons with HIV/AIDSA prospective on drug abuse-associated epigenetics and HIV-1 replication.Molecular mechanisms of HIV-1 mother-to-child transmission and infection in neonatal target cells.Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy.Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission.Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.Cocaine modulates HIV-1 integration in primary CD4+ T cells: implications in HIV-1 pathogenesis in drug-abusing patientsMorphine stimulates CCL2 production by human neuronsHeroin Use and HIV Disease Progression: Results from a Pilot Study of a Russian Cohort.Psychiatric Symptoms, Salivary Cortisol and Cytokine Levels in Young Marijuana Users.The HIV Epidemic: High-Income Countries.Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits.Improvement in the health of HIV-infected persons in care: reducing disparities.Methamphetamine induces trace amine-associated receptor 1 (TAAR1) expression in human T lymphocytes: role in immunomodulation.Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC).Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program.Impact of opiate addiction on neuroinflammation in HIV.Impact of HIV and a history of marijuana dependence on procedural learning among individuals with a history of substance dependence.Substance abuse, HIV-1 and hepatitisCannabis in sport: anti-doping perspective.Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women.The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study.Predictive factors of herpes zoster HIV-infected patients: another adverse effect of crack cocaine.HIV infection and drugs of abuse: role of acute phase proteins.Methamphetamine inhibits HIV-1 replication in CD4+ T cells by modulating anti-HIV-1 miRNA expression.Epigenetics, drugs of abuse, and the retroviral promoter.Role of the mu-opioid receptor in opioid modulation of immune function.Acceleration of cardiovascular-biological age by amphetamine exposure is a power function of chronological age.
P2860
Q21203516-CCFF3830-F10B-43FA-A7C7-81521BAC827EQ26779435-DCC19732-2A52-4A8A-9C62-26FB77C0EFB7Q26782833-28558DA4-7845-4709-B127-86E7CE729FC1Q28477883-DCB37BDC-4312-460A-947C-18998D0390A2Q28478866-3ADD24F7-C548-49B3-AEA2-9C7F4306C982Q28484311-D1BB4C6E-DA8D-4DFD-A45B-4052A08F02DAQ33492589-88E765E0-EC79-4A39-A7ED-058C86BAF0BCQ33660210-84B4D1F2-7F37-49BC-A917-AD313F6A65B7Q33712066-A51A6E0B-E37D-4B50-B6CD-BBBFEB236D43Q33733529-B935C95B-BD55-4287-8014-2B2D0BF5267CQ33852354-AB19F71D-4EA1-4DA3-900A-E2526A40B102Q34097854-F03ED9FF-80F4-4F64-A1EB-880E2DAF2CA0Q34263901-C7818021-90E4-4498-AE67-781CBE8AE553Q34612737-0A3B6E00-1C7E-41CB-8CD9-29B5F5C60873Q34626428-7627D5D1-55EA-463F-BDC0-FD07B1486CF3Q34851665-F2B54B0E-8C83-45AA-A1DF-171D1B4ABFACQ35000633-3B87B8D5-C3D1-4D02-82B4-C2EEAD70C19CQ35000656-73B0271B-3071-492B-A1A8-E01C92A1F070Q35207116-4DE1D7E0-9469-4B97-91EB-36D835CE9D37Q35238188-560FA380-5692-4A54-908C-BF7F0D1DEFF7Q35634735-A21627C6-E32B-4DA4-8333-0F6B2B6F2C58Q35751939-197B24F6-F8AF-4A33-A065-FB9ADC7D36AFQ35902684-D064E957-95D1-4484-B6E7-B498EED3FA57Q36237418-148F4D30-7012-4DFF-B3C4-1B34926A4154Q36303074-0AEA5769-5C5B-400B-AEF2-2D0F5519134FQ36356992-8919F9A7-6FFF-43F1-A42A-D82015C93B74Q36392409-4315974C-7CC6-4774-B6EB-DB96DD1BDB39Q36398092-716DABC5-3FAA-4067-AB29-0824CD3AE0EEQ36612468-CE667880-D291-424D-8047-54C20536B34BQ36787826-A8FB6BB4-0A70-4092-8951-94650A5C4323Q37003023-8F12F301-2F27-4F21-BCD7-FCB6470498EFQ37029485-4C1C2760-51CB-4700-854E-3CC257221E57Q37104874-B00C9731-0E46-4431-9015-C64393A2BFDDQ37275623-2BB66B12-3803-401E-AB5A-E76198033D81Q37297444-6A21AE8C-CD90-470A-B613-D4B5D26364E4Q37359240-C504AE6C-9948-4249-97C3-4B3ED81708A0Q37415416-745F0D8C-9647-469C-9FFC-71529006048EQ37425468-2DF632A8-9312-4CB4-B348-B3FC9433740FQ37551339-B357EF56-9658-45C9-A412-E080BDF620F1Q37640278-E757944D-A1F7-488A-B729-9EF88E5A9D7F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drugs of abuse, immune modulation, and AIDS.
@en
Drugs of abuse, immune modulation, and AIDS.
@nl
type
label
Drugs of abuse, immune modulation, and AIDS.
@en
Drugs of abuse, immune modulation, and AIDS.
@nl
prefLabel
Drugs of abuse, immune modulation, and AIDS.
@en
Drugs of abuse, immune modulation, and AIDS.
@nl
P2860
P1476
Drugs of abuse, immune modulation, and AIDS.
@en
P2093
Guy A Cabral
P2860
P2888
P304
P356
10.1007/S11481-006-9023-5
P577
2006-06-28T00:00:00Z